3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 33.10
+0.45 (1.38%)
Sep 30, 2026, 1:31 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 2.51 billion as of September 29, 2026. Its market cap has decreased by -32.66% in one year.
Market Cap
2.51B
Enterprise Value
2.06B
Revenue
159.19M
Ranking
n/a
PE Ratio
177.61
Stock Price
33.10
ChartMarket Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has decreased from 2.74B to 2.51B, a decrease of -8.14%. That is a compound annual growth rate of -1.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 2.51B | -33.15% |
| Dec 31, 2025 | 3.76B | -26.72% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Intech Biopharm | 2.63B |
| Chunghwa Chemical Synthesis & Biotech | 2.59B |
| GlycoNex Incorporation | 2.47B |
| HeXun Biosciences | 2.31B |
| Taiwan Bio Therapeutics | 2.22B |
| Syngen Biotech | 2.13B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.11B |
| G&E Herbal Biotechnology | 1.99B |